伤口护理市场 - 全球产业规模、份额、趋势、机会及预测（按治疗方法、伤口类型、应用、最终用户、地区和竞争格局划分，2021-2031年）

全球伤口护理市场预计将从 2025 年的 234.7 亿美元成长到 2031 年的 337.9 亿美元，复合年增长率为 6.26%。

此领域涵盖多种产品，包括医用敷料、活性疗法以及旨在促进急性和慢性伤害止血和组织再生的专用器械。推动这一增长的关键因素是全球文明病（尤其是糖尿病）盛行率的上升，这导致需要长期管理的复杂溃疡的发生率增加。根据国际糖尿病联盟 (IDF) 预测，到 2024 年，全球将有约 5.89 亿成年人患有糖尿病，这将形成一个皮肤併发症高风险族群。此外，人口老化导致手术干预频率增加，从而对术后护理产生了持续的需求。

然而，先进生物活性疗法的高昂成本是市场扩张的一大障碍。新兴国家严格的报销政策往往迫使​​医疗服务提供者转向传统的、成本较低的替代方案。这种经济障碍阻碍了高品质治疗方案的广泛应用，并限制了价格敏感型地区的市场成长。

市场驱动因素

老年人口的快速成长及其伴随而来的老龄化易感性正在从根本上改变市场模式。老年人的生理变化使其患有难以癒合的慢性疾病的风险显着增加，从而催生了对持续临床干预和治疗方案的需求。随着医疗保健机构寻求有效治疗方法复杂溃疡和压疮的方法，这种人口结构的变化正直接推动主要产业参与者的商业性成长。例如，根据科乐普公司于2024年11月发布的2023/24年度报告，该公司的高级创伤护理业务在全球市场强劲需求的推动下实现了10%的内部成长。这一增长凸显了全球人口老化与对专业伤口管理产品日益增长的需求之间的重要连结。

此外，先进伤口敷料和智慧疗法的技术创新是推动市场发展的另一个关键因素。製造商正日益将负压伤口治疗和生物活性材料等主动机制融入产品中，以促进传统敷料无法有效治疗的复杂病例的癒合。这些创新透过缩短復健时间改善了患者的治疗效果，同时减轻了医疗保健系统的整体经济负担。为了反映这一趋势，史密斯医疗（Smith & Nephew）在2024年2月发布的「2023年第四季及全年业绩」报告中指出，其先进伤口护理设备部门的收入实现了14.9%的潜在增长。此外，莫尔尼克（Molnrike）公布的2024财年和2023财年净销售额均创历史新高，达到19.24亿欧元，进一步印证了该部门的强劲财务表现，也印证了市场的良好前景。

市场挑战

先进生物活性疗法的高成本严重阻碍了全球伤口护理市场的扩张。细胞和组织疗法等高价值产品的高价往往超出公共医疗系统和私人支付方的预算，尤其是在对价格敏感的发展中地区。因此，健保机构设定了严格的资格标准，迫使医疗服务提供者优先选择传统的低成本敷料，而非更有效但价格更高的再生医学疗法。这种经济限制直接抑制了先进疗法的应用，降低了市场渗透率和整体收入潜力。

慢性伤口併发症的整体治疗成本巨大，加剧了医疗负担，迫使管理者限制每位患者的支出。根据英国糖尿病协会（Diabetes UK ）统计，到2024年，治疗糖尿病相关併发症（包括复杂的足部溃疡和截肢）的年度医疗费用将达到62亿英镑。如此庞大的伤口管理支出使得严格的成本控制措施势在必行，从而限制了用于先进生物活性疗法的资金，并阻碍了该领域的发展。

市场趋势

生物活性和组织工程疗法的兴起正在迅速改变复杂难癒合伤口的治疗标准。市场正从传统的被动商业性转向以细胞和组织为基础的产品（CTP），这些产品在结构上模拟细胞外基质并主动促进组织再生。这一趋势的特点是，先进的皮肤替代物在临床实践中得到加速应用，这主要得益于它们能够闭合传统治疗方法无效的顽固性溃疡。该行业近期的财务业绩也印证了对这种高品质再生医学解决方案的强劲需求。 Organogenesis Holdings, Inc. 于 2025 年 2 月发布的「2024 年第四季财务业绩」显示，其先进创伤护理产品的净销售额年增 27%，凸显了这些专业治疗方法的市场显着扩张。

同时，采用内建即时感测器的智慧敷料已成为一项关键趋势，推动医疗领域从被动治疗转向主动监测。製造商正越来越多地将诊断微型感测器直接整合到纺织品中，以持续追踪温度和压力等生理参数，从而在糖尿病足溃疡等併发症发生之前就进行早期检测。将数位健康功能整合到实体敷料中，代表着预防医学的新前沿，并吸引了大量资本投资。例如，2025年1月，Molnlycke Healthcare宣布向糖尿病足溃疡管理系统公司Siren投资800万美元，以支持其配备感测器的可穿戴技术的发展，该技术可用于早期检测患者的组织损伤。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球伤口护理市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 治疗方法（器械治疗、血小板治疗、细胞治疗、伤口敷料、其他）
  • 依伤口类型（腹部皮下伤口、创伤/感染性伤口、双侧乳房缩小术伤口、其他）
  • 用于（烧烫伤、溃疡、割伤/撕裂伤等）
  • 按最终使用者（医院/诊所、门诊手术中心、居家医疗、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美伤口护理市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲伤口护理市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区伤口护理市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲伤口护理市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲伤口护理市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球伤口护理市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• 3M Company
• ConvaTec Group PLC
• MOlnlycke Health Care AB
• Smith & Nephew plc
• Organogenesis Incx
• Coloplast A/S
• MiMedx Group Inc.
• Integra LifeSciences Corporation
• Johnson & Johnson
• Medtronic Plc

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Wound Treatment Market is projected to expand from USD 23.47 Billion in 2025 to USD 33.79 Billion by 2031, reflecting a CAGR of 6.26%. This sector encompasses a range of products, including medical dressings, active therapies, and specialized devices intended to facilitate hemostasis and encourage tissue regeneration in both acute and chronic injuries. A primary factor driving this growth is the rising global prevalence of lifestyle-related diseases, particularly diabetes, which leads to a higher incidence of complex ulcers necessitating extended management. According to the International Diabetes Federation, approximately 589 million adults were living with diabetes worldwide in 2024, creating a significant patient demographic susceptible to skin complications. Furthermore, an aging population contributes to sustained demand for postsurgical care due to the increased frequency of surgical interventions.

However, a major obstacle hindering market expansion is the prohibitive cost associated with advanced bioactive therapies. Rigid reimbursement policies in emerging economies frequently compel healthcare providers to rely on traditional, less expensive alternatives. This economic barrier prevents the widespread adoption of premium treatment solutions and restricts growth in regions where price sensitivity is a critical factor.

Market Driver

The rapid growth of the geriatric population and their inherent susceptibility to age-related wounds are fundamentally reshaping the market landscape. As older adults undergo physiological changes, they face a significantly higher risk of developing hard-to-heal chronic conditions, creating a consistent need for clinical interventions and therapeutic solutions. This demographic shift directly fuels commercial growth for key industry players as healthcare providers seek effective treatments for complex ulcers and pressure injuries. For instance, Coloplast's 'Annual Report 2023/24', published in November 2024, reported that its Advanced Wound Care business achieved an organic growth rate of 10%, driven largely by strong demand across global markets. This increase underscores the critical link between an aging global populace and the escalating requirement for specialized wound management products.

Additionally, technological advancements in advanced wound dressings and smart therapies act as a second pivotal force propelling market progression. Manufacturers are increasingly integrating active mechanisms, such as negative pressure wound therapy and bioactive materials, to accelerate healing in complex cases where traditional dressings are insufficient. These innovations improve patient outcomes while reducing the overall economic burden on healthcare systems by shortening recovery times. Reflecting this trend, Smith+Nephew reported in February 2024, within their 'Fourth Quarter and Full Year 2023 Results', that Advanced Wound Devices revenue increased by 14.9% on an underlying basis. Further validating the sector's financial health, Molnlycke reported record high annual net sales of EUR 1,924 million for the fiscal year 2023 in 2024, confirming the market's positive trajectory.

Market Challenge

The prohibitive cost associated with advanced bioactive therapies presents a formidable barrier to the expansion of the Global Wound Treatment Market. High pricing for these premium products-such as cellular and tissue-based solutions-often exceeds the budgetary constraints of public health systems and private payers, particularly in price-sensitive developing regions. Consequently, reimbursement bodies enforce strict coverage criteria, forcing healthcare providers to prioritize traditional, lower-cost dressings over more effective but expensive regenerative solutions. This economic limitation directly stifles the volume of adoption for advanced therapies, reducing their market penetration and overall revenue potential.

This financial strain is intensified by the massive aggregate expense of managing chronic wound complications, which compels administrators to limit per-patient spending. According to Diabetes UK, in 2024, the annual cost to the healthcare system for treating diabetes-related complications, including complex foot ulcers and amputations, reached £6.2 billion. This substantial baseline expenditure on wound management necessitates rigorous cost-containment measures, thereby restricting the funds available for sophisticated bioactive treatments and hampering the sector's growth trajectory.

Market Trends

The rise of Bioactive and Regenerative Tissue Engineering Therapies is rapidly redefining the standard of care for complex, hard-to-heal injuries. Moving away from traditional passive treatments, the market is witnessing a decisive commercial shift toward cellular and tissue-based products (CTPs) that structurally mimic the extracellular matrix to actively stimulate tissue regeneration. This trend is characterized by the accelerated adoption of advanced skin substitutes in clinical settings, driven by their ability to close refractory ulcers that fail to respond to conventional management. This robust demand for premium regenerative solutions is substantiated by recent financial performance in the sector; according to Organogenesis Holdings Inc., in their 'Fourth Quarter 2024 Financial Results' released in February 2025, net revenue from Advanced Wound Care products increased by 27% compared to the prior year, highlighting the significant market expansion of these specialized therapies.

Simultaneously, the adoption of Smart Dressings with Embedded Real-Time Sensors is emerging as a critical trend, shifting the sector from reactive treatment to proactive monitoring. Manufacturers are increasingly embedding diagnostic microsensors directly into textiles to continuously track physiological parameters such as temperature and pressure, enabling the early detection of complications like diabetic foot ulcers before they develop. This integration of digital health capabilities into physical dressings represents a new frontier in preventative care, attracting substantial capital investment. For example, in January 2025, Molnlycke Health Care announced a USD 8 million investment in Siren, a diabetic foot ulcer management system company, to support the expansion of sensor-based wearable technologies designed for the early detection of patient tissue damage.

Key Market Players

• 3M Company
• ConvaTec Group PLC
• MOlnlycke Health Care AB
• Smith & Nephew plc
• Organogenesis Incx
• Coloplast A/S
• MiMedx Group Inc.
• Integra LifeSciences Corporation
• Johnson & Johnson
• Medtronic Plc

Report Scope

In this report, the Global Wound Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wound Treatment Market, By Therapy

• Instrumental Based Therapy
• Platelet Therapy
• Cell Therapy
• Wound Dressing
• Others

Wound Treatment Market, By Wound Type

• Subcutaneous Abdominal Wound
• Traumatic & Infected Wound
• Bilateral Reduction Mammaplasty Wound
• Others

Wound Treatment Market, By Application

• Burns
• Ulcers
• Cuts & Lacerations
• Others

Wound Treatment Market, By End User

• Hospitals & Clinics
• Ambulatory Surgery Centers
• Homecare
• Others

Wound Treatment Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Wound Treatment Market.

Available Customizations:

Global Wound Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wound Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Therapy (Instrumental Based Therapy, Platelet Therapy, Cell Therapy, Wound Dressing, Others)
  • 5.2.2. By Wound Type (Subcutaneous Abdominal Wound, Traumatic & Infected Wound, Bilateral Reduction Mammaplasty Wound, Others)
  • 5.2.3. By Application (Burns, Ulcers, Cuts & Lacerations, Others)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Homecare, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Wound Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Therapy
  • 6.2.2. By Wound Type
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Wound Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Therapy
      • 6.3.1.2.2. By Wound Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Wound Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Therapy
      • 6.3.2.2.2. By Wound Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Wound Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Therapy
      • 6.3.3.2.2. By Wound Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Wound Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Therapy
  • 7.2.2. By Wound Type
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Wound Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Therapy
      • 7.3.1.2.2. By Wound Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Wound Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Therapy
      • 7.3.2.2.2. By Wound Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Wound Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Therapy
      • 7.3.3.2.2. By Wound Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Wound Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Therapy
      • 7.3.4.2.2. By Wound Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Wound Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Therapy
      • 7.3.5.2.2. By Wound Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Wound Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Therapy
  • 8.2.2. By Wound Type
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Wound Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Therapy
      • 8.3.1.2.2. By Wound Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Wound Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Therapy
      • 8.3.2.2.2. By Wound Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Wound Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Therapy
      • 8.3.3.2.2. By Wound Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Wound Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Therapy
      • 8.3.4.2.2. By Wound Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Wound Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Therapy
      • 8.3.5.2.2. By Wound Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Wound Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Therapy
  • 9.2.2. By Wound Type
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Wound Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Therapy
      • 9.3.1.2.2. By Wound Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Wound Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Therapy
      • 9.3.2.2.2. By Wound Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Wound Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Therapy
      • 9.3.3.2.2. By Wound Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Wound Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Therapy
  • 10.2.2. By Wound Type
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Wound Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Therapy
      • 10.3.1.2.2. By Wound Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Wound Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Therapy
      • 10.3.2.2.2. By Wound Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Wound Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Therapy
      • 10.3.3.2.2. By Wound Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Wound Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. 3M Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. ConvaTec Group PLC
• 15.3. MOlnlycke Health Care AB
• 15.4. Smith & Nephew plc
• 15.5. Organogenesis Incx
• 15.6. Coloplast A/S
• 15.7. MiMedx Group Inc.
• 15.8. Integra LifeSciences Corporation
• 15.9. Johnson & Johnson
• 15.10. Medtronic Plc

16. Strategic Recommendations

17. About Us & Disclaimer